Overview: Ferric Chloride TestIntroduction: The Ferric Chloride Test detects phenylketones in urine to diagnose phenylketonuria, causing developmental delays. Following 2023 ACMG guidelines, it uses spectrophotometry for high specificity, aiding in metabolic screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in clinical pathology for patients with suspected phenylketonuria.
Other Names: Phenylketonuria Urine Test, PKU Screening Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Phenylketonuria testing began in the 1960s with newborn screening. Ferric chloride assays emerged in the 1970s, and by the 2000s, improved methods enhanced accuracy.
Purpose: Diagnoses phenylketonuria, guides dietary management, and monitors phenylketones in patients with developmental delays.
Test Parameters: 1. Phenylketones
Pretest Condition: No fasting required. Collect urine at any time. Report symptoms like developmental delays, and list family history of metabolic disorders.
Specimen: 5-20 mL urine (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document developmental delays or family history of phenylketonuria. Include current medications or dietary restrictions.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for dietary management.
Procedural Considerations: Uses spectrophotometry to detect phenylketones in urine. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Contamination or dietary factors can affect results. Early testing may yield false negatives.
Clinical Significance: Positive phenylketone results confirm phenylketonuria, prompting dietary management. Negative results may require genetic testing.
Specialist Consultation: Consult a metabolic specialist or geneticist for result interpretation.
Additional Supporting Tests: Phenylalanine levels, PAH gene testing, or newborn screening panel to confirm phenylketonuria.
Test Limitations: False negatives may occur in early disease. Results require clinical correlation.
References: ACMG PKU Guidelines, 2023; Journal of Inherited Metabolic Disease, Blau N, 2022.
